National Institute of Neurological Disorders and Stroke; Amended Notice of Meetings, 44689 [2024-11075]
Download as PDF
Federal Register / Vol. 89, No. 99 / Tuesday, May 21, 2024 / Notices
6021 Bethesda, MD 20892, (301) 496–9350,
sheila.pirooznia@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Education Activities for Responsible
Analyses of Complex, Large-Scale Data.
Date: July 3, 2024.
Time: 2:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Li Rebekah Feng, Ph.D.,
Scientific Review Officer, Division of
Extramural Review, Scientific Review
Branch, National Institute on Drug Abuse,
NIH, 301 North Stonestreet Avenue, MSC,
6021 Bethesda, MD 20892, (301) 827–7245,
rebekah.feng@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Targeting Inflammasomes in HIV and
Substance Use.
Date: July 8, 2024.
Time: 10:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Soyoun Cho, Ph.D.,
Scientific Review Officer, Division of
Extramural Research, Scientific Review
Branch, National Institute on Drug Abuse,
NIH, 301 North Stonestreet Avenue, MSC,
6021 Bethesda, MD 20892, (301) 594–9460,
Soyoun.cho@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Dated: May 15, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–11068 Filed 5–20–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
ddrumheller on DSK120RN23PROD with NOTICES1
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Amended Notice
of Meetings
Notice is hereby given of a change in
the meetings of the National Institute of
Neurological Disorders and Stroke
Special Emphasis Panel, VCID Center
Without Walls, June 11, 2024, 10:00
a.m. to 6:00 p.m.; BRAIN Initiative
Connectivity across Scales Data
VerDate Sep<11>2014
18:13 May 20, 2024
Jkt 262001
Coordinating Center (BRAIN
CONNECTS DCC) (U24 Clinical Trial
Not Allowed), June 13, 2024, 10:00 a.m.
to 12:30 p.m.; and BRAIN Initiative:
Research Resource Grants for
Technology Integration and
Dissemination (U24 Clinical Trial Not
Allowed), June 20, 2024, 10:00 a.m. to
6:00 p.m., National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD, 20852 which
were published in the Federal Register
on May 15, 2024, FR Doc. 2024–10633,
89 FR 42479.
This notice is being amended to
change the meeting formats of all three
meetings from in-person to virtual. The
dates and times of these meetings will
remain the same. The meetings are
closed to the public.
Dated: May 15, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–11075 Filed 5–20–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Amended Notice
of Meeting
Notice is hereby given of a change in
the meeting of the National Institute of
Neurological Disorders and Stroke
Special Emphasis Panel, HEAL
Initiative: Digital Biomarker, June 04,
2024, 10:00 a.m. to June 04, 2024, 06:00
p.m., National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD, 20852 which
was published in the Federal Register
on May 13, 2024, FR Doc 2024–10379,
89 FR 41451.
This notice is being amended to
change the meeting format from inperson to virtual. The date and time will
remain the same. The meeting is closed
to the public.
Dated: May 15, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–11074 Filed 5–20–24; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
44689
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings of the National
Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; Bioethics and Tech
Development.
Date: June 20, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Dem II,
Suite 920, 6707 Democracy Boulevard,
Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Debanjan Goswami, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Blvd., Suite 200, Bethesda, MD
20892, (301) 827–4614, debanjan.goswami@
nih.gov.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; Career Development
Awards (Ks) and Conference support (R13)
Review.
Date: June 25, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Dem II,
Suite 920, 6707 Democracy Blvd., Bethesda,
MD 20817 (Virtual Meeting).
Contact Person: Alexander O
Komendantov, Ph.D., Scientific Review
Officer, National Institute of Biomedical
Imaging and Bioengineering, National
Institutes of Health, 6707 Democracy Blvd.,
Suite 959, Bethesda, MD 20892, (301) 496–
2763, alexander.komendantov@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, National Institute of
Biomedical Imaging and Bioengineering,
National Institutes of Health.)
E:\FR\FM\21MYN1.SGM
21MYN1
Agencies
[Federal Register Volume 89, Number 99 (Tuesday, May 21, 2024)]
[Notices]
[Page 44689]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-11075]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Amended
Notice of Meetings
Notice is hereby given of a change in the meetings of the National
Institute of Neurological Disorders and Stroke Special Emphasis Panel,
VCID Center Without Walls, June 11, 2024, 10:00 a.m. to 6:00 p.m.;
BRAIN Initiative Connectivity across Scales Data Coordinating Center
(BRAIN CONNECTS DCC) (U24 Clinical Trial Not Allowed), June 13, 2024,
10:00 a.m. to 12:30 p.m.; and BRAIN Initiative: Research Resource
Grants for Technology Integration and Dissemination (U24 Clinical Trial
Not Allowed), June 20, 2024, 10:00 a.m. to 6:00 p.m., National
Institutes of Health, Neuroscience Center, 6001 Executive Boulevard,
Rockville, MD, 20852 which were published in the Federal Register on
May 15, 2024, FR Doc. 2024-10633, 89 FR 42479.
This notice is being amended to change the meeting formats of all
three meetings from in-person to virtual. The dates and times of these
meetings will remain the same. The meetings are closed to the public.
Dated: May 15, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-11075 Filed 5-20-24; 8:45 am]
BILLING CODE 4140-01-P